GLP-1s: Promise and problems "GLP-1 medications are great, and there are similar promising drugs in the pipeline," says Dr
Limited human data exists about GLP-1 medications transferring into breast milk, making safety during breastfeeding unclear
Tirzepatide is administered in the form of weekly injections
It is approved for individuals with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have at least one weight-related condition such as high blood pressure, high cholesterol, or sleep apnea
All GWASs were adjusted for inflation using genomic control, with the inflation factor being no more than 1.035 in all phenotypes
Despite the minority of people for whom these drugs dont work, their introduction promises to provide significant health benefits to millions of people who have previously struggled to lose weight.